Advertisement
Advertisement

OSCR

OSCR logo

Oscar Health, Inc.

14.35
USD
Sponsored
-0.58
-3.90%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

14.30

-0.05
-0.33%

OSCR Earnings Reports

Positive Surprise Ratio

OSCR beat 10 of 19 last estimates.

53%

Next Report

Date of Next Report
Feb 10, 2026
Estimate for Q4 25 (Revenue/ EPS)
$3.19B
/
-$0.90
Implied change from Q3 25 (Revenue/ EPS)
+6.71%
/
+69.81%
Implied change from Q4 24 (Revenue/ EPS)
+33.19%
/
+45.16%

Oscar Health, Inc. earnings per share and revenue

On Nov 06, 2025, OSCR reported earnings of -0.53 USD per share (EPS) for Q3 25, beating the estimate of -0.56 USD, resulting in a 6.64% surprise. Revenue reached 2.99 billion, compared to an expected 3.14 billion, with a -5.02% difference. The market reacted with a -2.76% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 13 analysts forecast an EPS of -0.90 USD, with revenue projected to reach 3.19 billion USD, implying an increase of 69.81% EPS, and increase of 6.71% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Old Republic International Corporation
Report Date
Jan 22, 2026 For Q4 25
Estimate
$0.89
Actual
$0.74
Surprise
-17.06%
FAQ
For Q3 2025, Oscar Health, Inc. reported EPS of -$0.53, beating estimates by 6.64%, and revenue of $2.99B, -5.02% below expectations.
The stock price moved down -2.76%, changed from $17.03 before the earnings release to $16.56 the day after.
The next earning report is scheduled for Feb 10, 2026.
Based on 13 analysts, Oscar Health, Inc. is expected to report EPS of -$0.90 and revenue of $3.19B for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement